OMB Reviews Int’l Drug-Price Index Plan, Keeping Pressure On Grassley

The White House budget office began reviewing CMS’ proposal to base Medicare Part B drug prices on prices paid abroad, increasing pressure on Senate Finance Committee members to reach a deal on alternative changes to the doctor reimbursement system for drugs and on industry to support those changes. The Office of Management and Budget began reviewing the proposed International Pricing Index demonstration a day after Finance Chair Chuck Grassley (R-IA) said he opposes relying on foreign governments to set drug...